Searchable abstracts of presentations at key conferences in endocrinology

ea0022p18 | Adrenal | ECE2010

The aldosterone renin ratio based on the plasma renin activity and the direct renin assay for diagnosing aldosterone-producing adenoma

Rossi GianPaolo , Barisa Marlena , Desideri GiovanBattista , Letizia Claudio , Maccario Mauro , Morganti Alberto , Palumbo Gaetana , Patalano Anna , Realdi Anna , Roman Elisabetta , Seccia Teresa Maria , Pessina Achille Cesare

The screening for primary aldosteronism (PA) is based on the aldosterone/renin ratio (ARR), which is calculated with the plasma renin activity (PRA) as denominator. A direct measurement of active renin (DRA) is being used as an alternative to PRA, but its diagnostic performance remains uncertain.Aim of the study was to head-to-head compare the ARR based on PRA (ARR-P) to on DRA (ARR-D), at baseline and post-captopril, for identifying aldosterone-producin...

ea0073aep19 | Adrenal and Cardiovascular Endocrinology | ECE2021

Aryl hydrocarbon receptor Interacting Protein (AIP) status in a functional adrenal adenoma occurring in a patient with a germline AIP mutation

Feola Tiziana , Capelli Roberta , Gianno Francesca , Compagnoni Chiara , Letizia Claudio , Toma Giorgio De , Ciardi Antonio , Vincentis Giuseppe De , Giangaspero Felice , Tessitore Alessandra , Marie-Lise Jaffrain-Rea

IntroductionAryl hydrocarbon receptor Interacting Protein (AIP), a pituitary tumour suppressing gene located in 11q13, is the most common predisposing gene for early-onset and familial acromegaly. Fifteen years after its identification, there is little evidence of AIP involvement in non-pituitary tumors. We had the opportunity to study AIP status in a cortisol-producing adenoma operated in an AIP mutation carrier.Case-report<p ...